Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AG vs GSK✓SelectedUSD · GSKAG vs GSK performance historyLatest closeAs of-7.18%11/16
Stock and ETF performance explorer

AG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.1%
GSK return
+107.3%
Excess return
-61.2%
Maximum drawdown
-80.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-7.2%-0.1%-7.1%-7.2%
7D-20.2%-1.3%-18.9%-19.8%
30D-20.7%+2.7%-23.4%-21.6%
3M-34.2%+2.7%-36.9%-35.0%
6M-37.8%+3.3%-41.2%-39.1%
YTD-23.8%+6.5%-30.3%-26.6%
1Y+5.7%+10.7%-5.0%+0.2%
3Y+142.1%+64.4%+77.8%+86.7%
5Y-4.7%+46.7%-51.4%-23.9%
10Y+46.1%+109.4%-63.2%-12.9%
All+46.1%+107.3%-61.2%-12.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling